News

Cardinal Health AccessClosure Acquisition Vascular Closure Devices Cath Lab

Cardinal Health announced an agreement to acquire privately held AccessClosure Inc. for $320 million. 

AccessClosure Next-Generation Vascular Closure Device ACC.14 March 2014

AccessClosure Inc. commercially launched itsMynx Ace vascular closure device, a safe and secure vascular closure product that provides consistent results with a new, easy-to-use deployment system...

AccessClosure Mynx Ace Vascular Closure Device Hemostasis Management Cath Lab

AccessClosure plans to launch the Mynx Ace Vascular Closure Device at the 2014 American College of Cardiology meeting, March 29-31. It is an upgrade of the company’s Mynx mechanical ...

Vascular Solutions ThrombiDisc Topical Hemostat Introducer Sheaths Cath Lab

Vascular Solutions Inc. launched the ThrombiDisc topical hemostat designed for use around...

hemostasis management cath lab safeguard medical systems datascope air-band

Merit Medical Systems Inc. announced that it has acquired Datascope Corp.’s Safeguard Pressure Assisted Device, which assists in obtaining and maintaining hemostasis after a femoral procedure and...

Vascular closure devices have a definite niche in areas where they were not originally intended but have found frequent off-label use because of their utility.

vascular closure device

Vascular closure devices (VCD) were first introduced in the early 1990s with a goal to achieve quick hemostasis, thus reducing patients’ stay in the hospital (shorter time to ambulation) as...

The U.S. Food and Drug Administration (FDA) accepted Biomedica’s Investigational New Drug (IND) application for ClotFoam, a novel hemostat for intraoperative hemorrhage. The company will now...

The U.S. District Court for the District of New Jersey approved an agreement under which Vascular Solutions Inc. will cease further manufacture, sales and distribution of its R-Band Radial...

Maquet Cardiovascular LLC has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and European CE mark approval for its new Air-Band Radial Compression Device....

Guardian II Hemostais Valve, recall

The U.S. Food and Drug Administration (FDA) notified healthcare professionals of a Class I recall of the Vascular Solutions Inc. Guardian II and Guardian II NC Hemostasis Valves. The firm is...

Terumo Medical Corp. announced it filed a patent infringement lawsuit against Vascular Solutions Inc. and Lepu Medical Technology (Beijing) Co. Ltd. in the U.S. District Court of New Jersey.

...

CardioLogical Solutions is an emerging cardiovascular device company formed by the merger of Emboline and VasoStitch and its breakthrough platform of accessory devices for transcatheter aortic...

Cardiva Medical FDA Pre Market Approval Vascade VCS

Cardiva Medical Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the Vascade Vascular Closure System (VCS). Clinical data from a prospective...

Vascular Closure Systems Inc. announced the successful conclusion of Phase I and Phase II of the first-in-human (FIH) clinical trial for its 6/7 French FastSeal Bioabsorbable Vascular Access...

November 6, 2012 — Vascular Solutions launched the R-Band radial hemostasis compression device in the United...

 An extracted bovine artery with an arteriotomy sealed by a MynxGrip closure dev

Vascular closure devices that use an active method to immediately seal the femoral access site can enable faster patient ambulation, reduce nursing time and speed discharge. However, one of...

Due to the increasing number of transcatheter aortic valve replacements (TAVR) and endovascular aneurysm repair (EVAR), a new startup company has developed a transfemoral combined access and...

Access site complications, hemostasis management, vascular closure

Percutaneous coronary interventional (PCI) procedures are performed throughout hundreds of US institutions every day. With the increasing frequency of these procedures being performed comes an...

July 6, 2012 — Vascular Closure Systems Inc. announced that the 30-day follow-up results for the Phase I first-in-human (FIH) clinicals have been confirmed by Doppler and ultrasound evaluation....

June 4, 2012 — SentreHeart Inc., a privately held medical device company, announced that it has recently completed a $26 million Series C financing led by Vivo Ventures, with participation by its...

May 4, 2012 - CardioDex announces initial commercial use of a new femoral access site closure device. Recent data from commercial use of the device on 41 patients at St. Marien Hospital in Siegen...

April 20, 2012 — VasoStitch will be featuring its technology at EuroPCR, Europe’s largest interventional cardiology scientific meeting, May 17, in Paris.

March 16, 2012 -- Kensey Nash Corp. today announced that the company has entered into a $39 million settlement agreement with St. Jude Medical, which resolves all disputes between the two...

February 28, 2012 — AccessClosure Inc. announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the MynxGrip Vascular Closure Device (VCD). Built on the Mynx platform, the...

January 17, 2012 – Nonstop nosebleeds can be serious and frightening, often sending people to the emergency room, where their noses are packed with gauze. When that doesn’t work, nosebleeds can be...

October 17, 2011 — The U.S. Food and Drug Administration (FDA) has approved LeGoo, a gel allowing surgeons to temporarily stop blood flow during surgery. This makes it possible to join blood...

September 27, 2011 — AccessClosure Inc. announced the shipment of its one millionth Mynx unit. The Mynx Vascular Closure Device received U.S. Food and Drug Administration (FDA) approval in May...

June 10, 2011 – The U.S. Food and Drug Administration (FDA) granted market clearance for a new vascular closure device (VCD) that uses a bioabsorbable plug to seal femoral artery puncture sites. The...
June 6, 2011 - AccessClosure Inc announced an exclusive agreement with Biosensors International for the distribution of the Mynx Vascular Closure Device throughout the United Kingdom, Switzerland and...
May 6, 2011 — In the case of angioplasty and stenting, readmission rates due to procedural complications are less than 1 percent, according to a study presented at the Society for Cardiovascular...

March 10, 2011 – The first study to compare pain associated with deployment of different vascular closure devices (VCD) as the primary endpoint has been published in the Journal of...

February 9, 2011 – The U.S. Food and Drug Administration (FDA) said certain lots of the Arstasis One femoral artery access system are part of a Class 1 recall. Components of the device may...

January 12, 2011 – A new, next-generation vascular closure device has been launched in the United States. The Mynx Cadence Vascular Closure Device (VCD), from AccessClosure, offers physicians...

January 7, 2011 – A new access device is now available in cath labs across the United States. The Arstasis One Access Device, from Arstasis, is the first commercially available alternative to the...

November 8, 2010 – Patient enrollment has begun in a trial looking at a new system for patients undergoing diagnostic angiography procedures through the femoral artery. The RECITAL study will...

October 6, 2010 – A new statement from the American Heart Association says arteriotomy closure devices are reasonable to use, but their benefits should be weighed against the risk of complications...

September 29, 2010 – An agreement was reached between AccessClosure and Benrikal Services for distributing vascular closure devices in the United States. AccessClosure will be the exclusive...

September 23, 2010 – The United States District Court for the District of New Hampshire entered a permanent injunction in a patent infringement lawsuit between two medical device companies.

September 1, 2010 - Z-Medica Corp., announced that it has signed an exclusive distribution agreement with Nihon-Kohden, Japan's manufacturer, developer and distributor of medical electronic...

July, 29, 2010 – A second generation transradial compression bracelet is designed to obtain a stable compression of the radial artery. The Zoom 2010 Transradial Compression Bracelet device from...

May 5, 2010 – A federal jury awarded more than $29.4 million in damages in a patent infringement lawsuit between two interventional cardiology access dressing manufacturers. Marine Polymer...

May 4, 2010 – The U.S. District Court in New Hampshire is being asked this week to review and reverse a jury verdict on patent litigation involving two companies with competing hemostasis...

April 26, 2010 – A vascular closure device using a single suture fitted with stainless steel rings was recently cleared by the U.S. Food and Drug Administration (FDA)

April 5, 2010 – The U.S. Food and Drug Administration (FDA) today said it approved the first absorbable fibrin sealant patch for use in cardiovascular surgery to prevent mild and moderate bleeding...

February 3, 2010 – The new Gator ClipSeal Plug is designed to maintain a hemostatic seal around 0.035- or 0.038-inch guide wires within large hemostatic valve introducer sheaths to minimize blood...

February 2, 2010 - A second-generation transradial compression bracelet, the Zoom 2010, is being released by Zoom Co Medic. This bracelet is designed to obtain a stable compression of the radial...

January 4, 2010 – The new design of the D-Stat Rad-Band incorporates a quick-release feature and a larger release tab, making it easier to detach the translucent comfort pad without disrupting...

August 18, 2009 – Cardiva Medical Inc. recently received FDA clearance for its Cardiva Catalyst III, which the company says is the first drug-coated vascular closure device for the intervention...

June 23, 2009 – AccessClosure yesterday launched its newest addition to the Mynx Vascular Closure family, the Mynx M5, which can be delivered directly through a small 5 Fr. cardiovascular sheath...

May 22, 2009 - CPC of America Inc. filed its first patent of a synthetic sealant for the MedClose Vascular Closure System (VCS), which is an internal puncture-closing system for use in...

February 25, 2009 - The HemCon Patch, a flexible hemostatic dressing from HemCon Medical Technologies Inc., is now available for external, temporary control of bleeding during interventional and...

December 30, 2008 - Merit Medical Systems Inc., a manufacturer of disposable devices used in cardiology and radiology procedures, today announced four developments regarding products and approvals...

October 14, 2008 - St. Jude Medical Inc. said today at TCT 2008 that the FDA and European CE Mark approval of the Angio-Seal Evolution Vascular Closure Device.

May 20, 2008 – Abbott launched the StarClose SE Vascular Closure System, a next-generation vessel closure device engineered to enable fast and secure closure of the femoral artery access site...

April 1, 2008 – A new high-performance bandage made from the same blood-stopping technology the U.S. Army uses in Afghanistan and Iraq was featured at ACC 2008.

When in direct contact with...

January 10, 2008 – The FDA today granted Ethicon Inc. an expanded indication for EVICEL Fibrin Sealant (Human), which is one of the first fibrin sealants available as an adjunct to hemostasis for...

January 7, 2008 - Cardica Inc. received nearly $2 million in payments from Cook Medical (Cook) for reaching milestones pursuant to its development agreements with Cook, including a vascular...

October 25, 2007 - Terumo Interventional Systems announced at TCT 2007 the launch of the TR Band, a radial artery compression device designed to safely and comfortably stop bleeding after...

October 18, 2007 - At TCT 2007, Radi Medical Systems Inc. focuses on the Femostop HD Femoral Compression System, that with the addition of a hemostatic dressing, promotes dual-action hemostasis,...

September 27, 2007 - Sutura Inc., a developer of minimally invasive vascular suturing devices, announced today that the first patient to receive a SuperStitch EL to close a Patent Foramen Ovale (...